Meuleman E J, Van Berkel J T, Rabsztyn P, Damen L
Academisch Ziekenhuis St. Radboud, afd., Urologie, Nijmegen.
Ned Tijdschr Geneeskd. 1998 Oct 24;142(43):2337-41.
Erectile dysfunction is a common but underreported condition. It is to be expected that the number of patients consulting their physician with the complaint of erectile dysfunction will increase considerably with the introduction of sildenafil (Viagra), the first oral drug that enhances penile erection. Sildenafil is an inhibitor of the enzyme phosphodiesterase type 5. It causes erection of the penis by allowing the relaxation of the smooth musculature of the cavernous body to persist. The first clinical results indicate that the treatment with sildenafil is safe and effective in the hands of a sexologically qualified physician. An erection disorder is essentially not more than a symptom which primarily requires causal therapy.
勃起功能障碍是一种常见但报告不足的病症。随着第一种增强阴茎勃起的口服药物西地那非(伟哥)的引入,可以预期因勃起功能障碍前来咨询医生的患者数量将大幅增加。西地那非是一种5型磷酸二酯酶抑制剂。它通过使海绵体平滑肌持续松弛来引起阴茎勃起。首批临床结果表明,在有性学资质的医生手中,使用西地那非进行治疗是安全有效的。勃起功能障碍本质上不过是一种症状,主要需要进行病因治疗。